Skip to content

Survivorship

Last updated: 30 May 2024
1/1
  1. Content:
Content:

Key points

  • Patients will transition back to primary care after finishing treatment for breast cancer.
  • Patients will continue to have surveillance screening for several years after treatment.
  • Some patients may worry about their risk of recurrence.

Content:

Follow-up care

Once patients have finished active treatment, they will transition to community care with follow-up appointments. Patients should continue to have surveillance screening at the hospital for five years, before they re-enrol with BreastScreen Aotearoa.

Guidelines for surveillance screening and follow-up care can be found in the Management of Early Breast Cancer - Evidence-based Best Practice Guidelines.

Breast Cancer Foundation NZ has a survivorship programme, Thriving, for those with early breast cancer in MidCentral DHB. Breast Cancer Foundation NZ also has a booklet available for patients to order after completing active treatment: Thriving After Breast Cancer

Long-term side effects of treatment

Patients may experience long-term side effects from their treatment, including lymphoedema.

Bibliography

  • Lawrenson, R., Lao, C., Ali, A. and Campbell, I. Impact of radiotherapy on cardiovascular health of women with breast cancer. J Med Imaging Radiat Oncol. 2019;63:250-256. doi:10.1111/1754-9485.12838 Journal
  • James M, Swadi S, Yi M, Johansson L, Robinson B, Dixit A. Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series. J Med Imaging Radiat Oncol. 2018;62:425-431. doi:10.1111/1754-9485.12712. Journal

Was this article helpful?

Suggest an edit

Suggest an edit

Would additional content be helpful on this page? Email suggestions and feedback to intouch@bcf.org.nz. Thank you.

This field is optional
(e.g.+6421 000 0000)